1. United Kingdom Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
MyHealthChecked PLC

MyHealthChecked PLC

MHC.L
MyHealthChecked PLCGB flagLondon Stock Exchange
8.75
GBp
-0.25
- -
4.55MMarket Cap
MyHealthChecked PLC
MHC.L
(London Stock Exchange)

Recent

price

8.75

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
FRC
- -
- -
- -
0.26
- -
- -
- -
0.01
- -
- -
- -
0.35
0.43
0.21
0.07
Revenue per Share
-14.75
-18.3
-19
-44.08
-22.28
-31.89
-0.54
-0.3
-0.27
-0.13
-0.13
0.04
0.03
- -
-0.03
Basic EPS, GAAP
-9.74
-11.79
-32.26
-110.48
-38.67
-6.95
-0.59
-0.4
-0.27
-0.14
-0.08
0.06
0.02
- -
-0.04
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-12.05
-27.41
-43.44
-80.97
-65.39
-89.58
-0.98
-0.42
-0.46
-0.32
-0.53
-0.25
-0.2
0.28
0.25
Book Value per Share
13.25
16.75
-9.91
- -
-15.75
-1.41
0.18
0.33
0.15
0.09
- -
0.1
0.15
0.14
0.11
Tangible Book Value per Share
- -
- -
- -
- -
- -
- -
2
8
11
16
28
47
52
52
52
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
16
22
11
4
Sales/Revenue/Turnover
- -
- -
- -
-9,381.82
- -
- -
-33,864.48
-2,262.79
-58,740.57
-7,721.56
-5,912
15.02
7.99
-2.24
-61.99
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
-1
-1
-1
-1
-2
-1
-2
-3
-2
-4
2
2
- -
-2
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
-16,663.64
- -
- -
-29,440.29
-2,168.94
-58,154.34
-6,725.22
-7,526
12.24
6.8
-1.45
-49.51
Profit Margin (%)
- -
- -
- -
- -
-1
- -
- -
2
1
1
- -
5
8
7
6
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
LT Debt
- -
- -
- -
1
1
- -
- -
3
2
2
1
7
9
9
7
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
60.23
21.65
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-15.12
-13.96
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-12.84
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
126.59%
233.74%
-19.86%
Free Cash Flow
-169.39%
-384%
-1,541.4%
Net Income, GAAP
103.86%
162.05%
1,023.27%
Sales/Revenue/Turnover
- -
6,525.34%
-67.14%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
11
2024
- -
- -
- -
- -
4
2025
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
-0.03
2025
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
Similar Companies
Lutronic Corp (085370.KS)
Tivic Health Systems, Inc. (TIVC)
Ion Beam Applications S.A. (IBAB.BR)
Surgical Innovations Group plc (SUN.L)
InMode Ltd. (INMD)
Intelligent Ultrasound Group plc (IUG.L)
Business
MyHealthChecked PLC develops, distributes, and commercializes at-home healthcare and wellness test kits primarily in the United Kingdom. The company offers a range of rapid diagnostic tests including general health blood tests, iron deficiency and ferritin rapid tests, vitamins and minerals DNA tests, ovulation tests, pregnancy tests, and comprehensive blood analysis panels; it also provides accompanying digital platforms for result interpretation, personalized health insights, and expert recommendations from healthcare professionals. Founded in 2008 and headquartered in Cardiff, Wales, MyHealthChecked PLC operates through retail partnerships across 800 UK stores and focuses on consumer markets seeking private health monitoring solutions. In November 2025, the company completed the sale of its core trading subsidiary Concepta Diagnostics Limited to Boots UK Limited for £2.4 million, positioning MyHealthChecked as a cash shell with approximately £5.7 million in reserves post-transaction and requiring a new acquisition under AIM Rule 14 within six months or facing trading suspension; the transaction transfers the MyHealthChecked brand intellectual property to Concepta, necessitating a name change, while CEO Penny McCormick joins Boots to lead its testing and diagnostics efforts. Previously known as Concepta PLC from 2016 to 2020, the firm shifted from women's fertility diagnostics to broader at-home wellness testing amid post-COVID market changes, including laboratory relocations and digital platform enhancements developed in partnership with Boots since 2021.